Research Article Open Access
Effects of Supersession Prescription/Metformin Combination Therapy in Overweight and Obese Individuals with Type 2 Diabetes
Yiyuan Zheng, Dan Fang, Miao Wang, Xiaogang Ma, Meng Xu and Songhua He
J Obes Weight-Loss Medic Volume 3, Issue 2
Abstract: This study was a 13-week, open-labeled, randomized parallel controlled study. Patients were randomly assigned to the treated and control groups in a 1:1 ratio. Both groups were provided metformin at the dosage of 750 mg twice daily as the primary treatment and the Supersession Prescription was given to the treated group as a supplementary treatment.